Paper17525730
Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens.
Jiménez M and 2 others. Leukemia, 2007. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens. Papers, record 17525730. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17525730
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graft vs Host Disease | Major topic |
| Stem Cell Transplantation | Major topic |
| T-Lymphocytes | Major topic |
| Transplantation Conditioning | Major topic |
| Graft vs Tumor Effect | |
| Humans | |
| Immunosuppressive Agents | |
| Transplantation Chimera | |
| Transplantation, Homologous |
Source PubMed
References97
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12393628 | Characterization of human blood dendritic cell subsets. | Blood | 2002 | https://conductscience.org/library/papers/12393628 | PubMed |
| 2 | 15526016 | Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning. | Leukemia | 2005 | https://conductscience.org/library/papers/15526016 | PubMed |
| 3 | 12201954 | Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants. | J Hematother Stem Cell Res | 2002 | https://conductscience.org/library/papers/12201954 | PubMed |
| 4 | 16263578 | Immune recovery after conventional and non-myeloablative allogeneic stem cell transplantation. | Leuk Lymphoma | 2005 | https://conductscience.org/library/papers/16263578 | PubMed |
| 5 | 10449519 | Direct evidence for thymic function in adult humans. | J Exp Med | 1999 | https://conductscience.org/library/papers/10449519 | PubMed |
| 6 | 12931226 | Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen. | Leukemia | 2003 | https://conductscience.org/library/papers/12931226 | PubMed |
| 7 | 11233907 | T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation. | Transplantation | 2001 | https://conductscience.org/library/papers/11233907 | PubMed |
| 8 | 9446633 | Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. | Blood | 1998 | https://conductscience.org/library/papers/9446633 | PubMed |
| 9 | 16258529 | Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients. | Bone Marrow Transplant | 2006 | https://conductscience.org/library/papers/16258529 | PubMed |
| 10 | 12472597 | Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality. | Br J Haematol | 2002 | https://conductscience.org/library/papers/12472597 | PubMed |
| 11 | 14755322 | Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus. | Bone Marrow Transplant | 2004 | https://conductscience.org/library/papers/14755322 | PubMed |
| 12 | 4398496 | Marrow transplanation in man following cyclophosphamide. | Transplant Proc | 1971 | https://conductscience.org/library/papers/4398496 | PubMed |
| 13 | 12243978 | Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation. | Hematology | 2002 | https://conductscience.org/library/papers/12243978 | PubMed |
| 14 | 11593319 | Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism. | Bone Marrow Transplant | 2001 | https://conductscience.org/library/papers/11593319 | PubMed |
| 15 | 9872319 | Changes in thymic function with age and during the treatment of HIV infection. | Nature | 1998 | https://conductscience.org/library/papers/9872319 | PubMed |
| 16 | 9521319 | Dendritic cells and the control of immunity. | Nature | 1998 | https://conductscience.org/library/papers/9521319 | PubMed |
| 17 | 9034287 | Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. | Am J Hematol | 1997 | https://conductscience.org/library/papers/9034287 | PubMed |
| 18 | 15846289 | Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: a comparison with their respective sibling donors. | Biol Blood Marrow Transplant | 2005 | https://conductscience.org/library/papers/15846289 | PubMed |
| 19 | 11274765 | Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation. | Exp Hematol | 2001 | https://conductscience.org/library/papers/11274765 | PubMed |
| 20 | 12652467 | Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease. | Biol Blood Marrow Transplant | 2003 | https://conductscience.org/library/papers/12652467 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41408960 | Factors Affecting Immune Reconstitution Post-Allogeneic HSCT in Children: The Case for an Individualized Approach to Vaccination. | Eur J Haematol | 2026 | https://conductscience.org/library/papers/41408960 | PubMed |
| 40336916 | Epstein-Barr virus reactivation after haplo-peripheral blood stem cell transplantation in patients with hematological malignancies: immune reconstitution and influence on survival. | Ther Adv Hematol | 2025 | https://conductscience.org/library/papers/40336916 | PubMed |
| 38680716 | Kinetics of Recovery of Naïve and Memory T Cells in Acute Leukemia Patients after Allogeneic Stem Cell Transplantation Depending on Different GVHD Prophylaxis Regimens. | Int J Hematol Oncol Stem Cell Res | 2024 | https://conductscience.org/library/papers/38680716 | PubMed |
| 37389818 | Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis. | Blood Adv | 2023 | https://conductscience.org/library/papers/37389818 | PubMed |
| 36105821 | Gamma delta T-cell reconstitution after allogeneic HCT: A platform for cell therapy. | Front Immunol | 2022 | https://conductscience.org/library/papers/36105821 | PubMed |
| 34057741 | A novel clinically relevant graft-versus-leukemia model in humanized mice. | J Leukoc Biol | 2022 | https://conductscience.org/library/papers/34057741 | PubMed |
| 31554929 | Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT). | Bone Marrow Transplant | 2020 | https://conductscience.org/library/papers/31554929 | PubMed |
| 30562587 | Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/30562587 | PubMed |
| 28991250 | Assessment of TREC, KREC and telomere length in long-term survivors after allogeneic HSCT: the role of GvHD and graft source and evidence for telomere homeostasis in young recipients. | Bone Marrow Transplant | 2018 | https://conductscience.org/library/papers/28991250 | PubMed |
| 28251017 | A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations. | Balkan Med J | 2017 | https://conductscience.org/library/papers/28251017 | PubMed |
| 27727179 | T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical Outcome. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27727179 | PubMed |
| 25961559 | Immune Reconstitution Kinetics following Intentionally Induced Mixed Chimerism by Nonmyeloablative Transplantation. | PLoS One | 2015 | https://conductscience.org/library/papers/25961559 | PubMed |
| 25867947 | Busulfan as a myelosuppressive agent for generating stable high-level bone marrow chimerism in mice. | J Vis Exp | 2015 | https://conductscience.org/library/papers/25867947 | PubMed |
| 25261095 | Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation. | Haematologica | 2015 | https://conductscience.org/library/papers/25261095 | PubMed |
| 25099175 | Myc and AP-1 expression in T cells and T-cell activation in patients after hematopoietic stem cell transplantation. | Clin Exp Med | 2015 | https://conductscience.org/library/papers/25099175 | PubMed |
| 23103674 | Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioning. | Bone Marrow Transplant | 2013 | https://conductscience.org/library/papers/23103674 | PubMed |
| 22856463 | Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies. | J Hematol Oncol | 2012 | https://conductscience.org/library/papers/22856463 | PubMed |
| 22046566 | Future perspectives: therapeutic targeting of notch signalling may become a strategy in patients receiving stem cell transplantation for hematologic malignancies. | Bone Marrow Res | 2011 | https://conductscience.org/library/papers/22046566 | PubMed |
| 21427289 | Thymic T-cell development in allogeneic stem cell transplantation. | Blood | 2011 | https://conductscience.org/library/papers/21427289 | PubMed |
| 20831896 | Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignancies. | Biol Blood Marrow Transplant | 2011 | https://conductscience.org/library/papers/20831896 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17525730
GET https://conductscience.org/api/papers/v1/17525730/references?page=2